Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors
Open Access
- 1 May 1992
- Vol. 69 (9), 2343-2348
- https://doi.org/10.1002/1097-0142(19920501)69:9<2343::aid-cncr2820690924>3.0.co;2-s
Abstract
The hypothesis that tumors arising in a particular organ site impose a characteristic plasma free amino acid (PFAA) pattern was tested by analyzing PFAA in fasting venous blood of preoperative patients with breast cancer, gastrointestinal tract cancer, and head and neck cancer. Healthy volunteers served as control subjects. Levels of 28 PFAA were determined in blood samples using an amino acid analyzer, and the data were compared using discriminant analysis and chi‐square testing. Compared with control subjects, the concentrations of seven amino acids (glutamine, threonine, histidine, cysteine, alanine, arginine, and ornithine) in patients with tumors correlated closely with the known diagnoses. By means of discriminant analysis, these seven amino acids had the highest correlation with the specific diagnoses, indicating that PFAA profiles correlate diagnostically with the organ‐site origin of three different kinds of malignant tumors.This publication has 18 references indexed in Scilit:
- Fasting plasma amino acid levels in cancer patientsCancer, 1985
- Whole-body tyrosine flux in relation to energy expenditure in weight-losing cancer patientsMetabolism, 1984
- Serum Amino Acid Levels in Patients With Hepatocellular CarcinomaCancer, 1984
- CANCER CACHEXIA AND PROTEIN METABOLISMThe Lancet, 1984
- Effect of parenteral nutrition on protein synthesis in adult cancer patientsThe American Journal of Clinical Nutrition, 1981
- The influence of tumor-bearing on protein metabolism in the ratJournal of Surgical Research, 1981
- Whole body protein turnover, synthesis and breakdown in patients with colorectal carcinomaBritish Journal of Surgery, 1980
- Peripheral amino acid levels in patients with cancerCancer, 1978
- A comparative study of the influence of malignant tumor on host metabolism in mice and man.Evaluation of an experimental modelCancer, 1978
- Effects of reducing the phenylalanine-Tyrosine intake of patients with advanced malignant melanomaCancer, 1966